James Investment Research’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-600
Closed -$17K 820
2017
Q2
$17K Hold
600
﹤0.01% 674
2017
Q1
$18K Hold
600
﹤0.01% 599
2016
Q4
$15K Hold
600
﹤0.01% 485
2016
Q3
$15K Hold
600
﹤0.01% 476
2016
Q2
$15K Hold
600
﹤0.01% 429
2016
Q1
$17K Hold
600
﹤0.01% 406
2015
Q4
$18K Hold
600
﹤0.01% 428
2015
Q3
$18K Sell
600
-400
-40% -$13K ﹤0.01% 413
2015
Q2
$35K Hold
1,000
﹤0.01% 387
2015
Q1
$35K Hold
1,000
﹤0.01% 402
2014
Q4
$35K Hold
1,000
﹤0.01% 403
2014
Q3
$35K Hold
1,000
﹤0.01% 408
2014
Q2
$40K Hold
1,000
﹤0.01% 387
2014
Q1
$40K Buy
+1,000
New +$36K ﹤0.01% 389

Other funds holding DBD

James Investment Research's DBD Position: Q3 2017 in Review

James Investment Research sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2017, closing a stake of 600 shares — an estimated $17K sold.

James Investment Research first reported a position in DBD in Q1 2014 and held it in 14 quarters. The position peaked at $40K in Q2 2014. 226 funds tracked by Wall St. Rank hold DBD as of Q3 2017.

  • James Investment Research reported no remaining Diebold Nixdorf Incorporated position as of Q3 2017 after selling out during the quarter.
  • James Investment Research sold 600 Diebold Nixdorf Incorporated shares in Q3 2017, an estimated $17K.
  • James Investment Research first reported a position in Diebold Nixdorf Incorporated in Q1 2014 and held it in 14 quarters.
  • James Investment Research's Diebold Nixdorf Incorporated position peaked at $40K in Q2 2014.
  • 226 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2017.

Based on James Investment Research's 13F filing for Q3 2017, filed 13 Oct 2017.